NeoDynamics

NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to improving diagnostics and care to optimize the outcome of individualized treatment in cancer. Our innovative pulse biopsy system, NeoNavia® is designed to offer clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis.

We focus on minimally invasive cancer diagnostic methods.

Our innovative precision biopsy system, NeoNavia® is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. The technology enables a more precise way to target lesions and secure high-quality tissue samples in both breast and axilla with flexibility for all types of Ultrasound Guided (USG) biopsies. The NeoNavia system ensures optimal needle control, with maximum tissue yield for any lesion type, size or location.

We at Neodynamics want to contribute to better diagnostic methods for the millions of women in the world who suffer from breast cancer each year, thereby increasing the chances of survival.

Anna Eriksrud, CEO of NeoDynamics